[{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Antibody","year":"2021","type":"Inapplicable","leadProduct":"FB825","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Intravenous Infusion","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Leo Pharma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Antibody","year":"2020","type":"Licensing Agreement","leadProduct":"FB825","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0.56999999999999995,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0.56999999999999995,"dosageForm":"Intravenous Infusion","sponsorNew":"Oneness Biotech \/ Leo Pharma","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Leo Pharma"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"TAIWAN","productType":"Other Large Molecule","year":"2023","type":"Inapplicable","leadProduct":"SNS812","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Inhalation","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Microbio","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"TAIWAN","productType":"Other Large Molecule","year":"2024","type":"Inapplicable","leadProduct":"SNS812","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Inhalation","sponsorNew":"Oneness Biotech \/ Microbio","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Microbio"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"TAIWAN","productType":"Other Large Molecule","year":"2023","type":"Inapplicable","leadProduct":"SNS812","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Inhalation","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Antibody","year":"2023","type":"Inapplicable","leadProduct":"FB825","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Subcutaneous Injection","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Oneness Biotech","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Fespixon","moa":"Undisclosed","graph1":"Podiatry","graph2":"Phase IV","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Oneness Biotech \/ Oneness Biotech","highestDevelopmentStatusID":"11","companyTruncated":"Oneness Biotech \/ Oneness Biotech"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"China Medical University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"TAIWAN","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Fespixon","moa":"Undisclosed","graph1":"Podiatry","graph2":"Phase IV","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Oneness Biotech \/ China Medical University Hospital","highestDevelopmentStatusID":"11","companyTruncated":"Oneness Biotech \/ China Medical University Hospital"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Taipei Veterans General Hospital | Taipei Medical University Shuang Ho Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"TAIWAN","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"ON101","moa":"Immune","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase IV","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Oneness Biotech \/ Taipei Veterans General Hospital | Taipei Medical University Shuang Ho Hospital","highestDevelopmentStatusID":"11","companyTruncated":"Oneness Biotech \/ Taipei Veterans General Hospital | Taipei Medical University Shuang Ho Hospital"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"TAIWAN","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"ON101","moa":"Immune","graph1":"Podiatry","graph2":"Phase III","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Cream","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"TAIWAN","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Xianglei Tangzu Gao","moa":"Undisclosed","graph1":"Podiatry","graph2":"Phase II\/ Phase III","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"9","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Antibody","year":"2020","type":"Inapplicable","leadProduct":"FB825","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Microbio Shanghai","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"TAIWAN","productType":"Antibody","year":"2021","type":"Inapplicable","leadProduct":"FB825","moa":"Undisclosed","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Oneness Biotech \/ Microbio Shanghai","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Microbio Shanghai"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Antibody","year":"2024","type":"Inapplicable","leadProduct":"FB825","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"TAIWAN","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"FB704A","moa":"OX40","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Oneness Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Oneness Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"TAIWAN","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"ON101","moa":"Immune","graph1":"Podiatry","graph2":"Phase III","graph3":"Oneness Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Cream","sponsorNew":"Oneness Biotech \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"Oneness Biotech \/ Inapplicable"}]
Find Clinical Drug Pipeline Developments & Deals by Oneness Biotech
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
